
Sign up to save your podcasts
Or
Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.
4.7
16081,608 ratings
Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.
4,084 Listeners
496 Listeners
3,195 Listeners
826 Listeners
2,174 Listeners
1,362 Listeners
3,368 Listeners
805 Listeners
1,489 Listeners
937 Listeners
2,317 Listeners
592 Listeners
384 Listeners
884 Listeners
1,546 Listeners
416 Listeners
236 Listeners